Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits

PURPOSE: To describe the pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits. METHODS: The right eye of 20 rabbits was injected intravitreally with 1.25 mg/0.05 mL bevacizumab. Both eyes of four rabbits each time were enucleated at days 1, 3, 8, 15, and 29. Bevacizumab concentration...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinapis, Christos I, Routsias, John G, Sinapis, Angelos I, Sinapis, Dimitrios I, Agrogiannis, George D, Pantopoulou, Alkistis, Theocharis, Stamatis E, Baltatzis, Stefanos, Patsouris, Efstratios, Perrea, Despoina
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104800/
https://www.ncbi.nlm.nih.gov/pubmed/21629577
http://dx.doi.org/10.2147/OPTH.S19555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104800/
https://www.ncbi.nlm.nih.gov/pubmed/21629577
http://dx.doi.org/10.2147/OPTH.S19555

Ejemplares similares